tricalcium phosphate has been researched along with Phosphorus Metabolism Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellinghieri, G; Santoro, D; Savica, V | 1 |
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
| Brancaccio, D; Cozzolino, M | 1 |
| Parfitt, AM | 1 |
2 review(s) available for tricalcium phosphate and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Emerging drugs for hyperphosphatemia.
Topics: Animals; Atherosclerosis; Calcinosis; Calcium Phosphates; Chelating Agents; Drugs, Investigational; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Saliva; Sevelamer; Uremia | 2007 |
Soft-tissue calcification in uremia.
Topics: Adult; Animals; Arteries; Arthritis; Calcinosis; Calciphylaxis; Calcium; Calcium Phosphates; Conjunctiva; Connective Tissue; Cornea; Eye Diseases; Female; Humans; Inflammation; Kidney Failure, Chronic; Phosphates; Phosphorus Metabolism Disorders; Radiography; Renal Dialysis; Skin Diseases; Uremia; Vascular Diseases | 1969 |
1 trial(s) available for tricalcium phosphate and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
1 other study(ies) available for tricalcium phosphate and Phosphorus Metabolism Disorders
| Article | Year |
|---|---|
Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease.
Topics: Atherosclerosis; Calcinosis; Calcium Phosphates; Chelating Agents; Drugs, Investigational; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer; Uremia | 2007 |